Molecular mechanisms of congenital heart disease in down syndrome

Area of Science:

• Genetics
• Developmental Biology
• Cardiology

Background:

• Down syndrome (DS) is a common genetic aneuploidy associated with numerous birth defects.
• Congenital heart disease (CHD) is a frequent complication, affecting 40-60% of neonates with DS.
• The precise molecular pathogenesis of DS-associated CHD remains incompletely understood.

Purpose of the Study:

• To provide a comprehensive and updated review of Down syndrome-associated congenital heart disease.
• To summarize current knowledge on the molecular mechanisms underlying DS-CHD.
• To consolidate findings from diverse studies for a holistic overview.

Main Methods:

• Literature review of studies on Down syndrome and congenital heart disease.
• Synthesis of research findings across seven key aspects of DS-associated CHD.
• Analysis of molecular and genetic factors implicated in DS-CHD.

Main Results:

• Down syndrome significantly increases the risk of various types of congenital heart defects.
• Several molecular pathways and genetic factors are implicated in the development of DS-CHD.
• Existing research provides a foundational understanding, but gaps remain in fully elucidating the mechanisms.

Conclusions:

• Congenital heart disease is a major health concern in Down syndrome, necessitating further research.
• Understanding the molecular basis of DS-CHD is crucial for potential therapeutic strategies.
• This review highlights the current state of knowledge and identifies areas for future investigation.